FdaApplication
ANDA 214131
Identifiers
- fda_app_no: ANDA214131
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-03-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LUBIPROSTONE | LUBIPROSTONE | 8MCG | CAPSULE;ORAL |
| LUBIPROSTONE | LUBIPROSTONE | 24MCG | CAPSULE;ORAL |
2 products